A 16-week open-label study on the efficacy and safety of canakinumab treatment in urticarial vasculitis

被引：0
|
作者：
Krause, K. [1 ]
Mahamed, A. [1 ]
Maurer, M. [1 ]
机构：
[1] Charit Univ Med Berlin, Dept Dermatol & Allergy, D-10117 Berlin, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2013年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E12 / E12
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of canakinumab in urticarial vasculitis: a single dose open label 16-week study
    Krause, K.
    Mahamed, A.
    Zuberbier, T.
    ALLERGY, 2012, 67 : 351 - 351
  • [2] Efficacy and safety of canakinumab in urticarial vasculitis: An open-label study
    Krause, Karoline
    Mahamed, Aos
    Weller, Karsten
    Metz, Martin
    Zuberbier, Torsten
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (03) : 751 - 754
  • [3] Pimecrolimus 1% cream in the treatment of facial psoriasis: A 16-week open-label study
    Jacobi, Arnd
    Braeutigam, Matthias
    Mahler, Vera
    Schultz, Erwin
    Hertl, Michael
    DERMATOLOGY, 2008, 216 (02) : 133 - 136
  • [4] No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial
    Haibel, H.
    Brandt, H. C.
    Song, I. H.
    Brandt, A.
    Listing, J.
    Rudwaleit, M.
    Sieper, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (03) : 419 - 421
  • [5] An open-label 16-week study of liraglutide in adolescents with obesity post-sleeve gastrectomy
    Zenno, Anna
    Nwosu, Ejike E.
    Fatima, Syeda Z.
    Nadler, Evan P.
    Mirza, Nazrat M.
    Brady, Sheila M.
    Turner, Sara A.
    Yang, Shanna B.
    Lazareva, Julia
    Te-Vasquez, Jennifer A.
    Chen, Kong Y.
    Chung, Stephanie T.
    Yanovski, Jack A.
    PEDIATRIC OBESITY, 2024, 19 (11):
  • [6] The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study
    Ketter, Terence A.
    Sachs, Gary S.
    Durgam, Suresh
    Lu, Kaifeng
    Starace, Anju
    Laszlovszky, Istvan
    Nemeth, Gyorgy
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 225 : 350 - 356
  • [7] Effectiveness and safety of etanercept in subjects with RA who have failed infliximab therapy: 16-week, open-label, observational study
    Bingham, Clifton O., III
    Ince, Akgun
    Haraoui, Boulos
    Keystone, Edward C.
    Chon, Yun
    Baumgartner, Scott
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (05) : 1131 - 1142
  • [8] First episode depression and monotherapy with escitalopram: A 16-week, open-label, flexible-dose study
    Ravindran, Arun V.
    Harkness, Kate
    Ravindran, Lakshmi
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 81 - 81
  • [9] A 16-Week Open-Label Study of the Effects of Treatment With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis
    Evidente, Virgilio G. H.
    DeKarske, Daryl
    Coate, Bruce
    Naujoks, Karla
    Abler, Victor
    CNS SPECTRUMS, 2023, 28 (02) : 239 - 239
  • [10] Augmentation of Clozapine With Agomelatine in Partial-Responder Schizophrenia A 16-Week, Open-Label, Uncontrolled Pilot Study
    Bruno, Antonio
    Zoccali, Rocco A.
    Abenavoli, Elisabetta
    Pandolfo, Gianluca
    Scimeca, Giuseppe
    Spina, Edoardo
    Muscatello, Maria Rosaria Anna
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (04) : 491 - 494
12345